it may lead to surgical complication in the form of impaired wound healing following oral and maxillofacial surgery periodontal surgery or endodontic therapy particular medications can result in mronj a serious but uncommon side effect in certain individuals such medications are frequently used to treat diseases that cause bone resorption such as osteoporosis or to treat cancer the main groups of drugs involved are anti resorptive drugs and anti angiogenic drugs this condition was previously known as bisphosphonate related osteonecrosis of the jaw bon or bronj because osteonecrosis of the jaws correlating with bisphosphate treatment was frequently encountered with its first incident occurring in 2003 osteonecrotic complications associated with denosumab another antiresorptive drug from a different drug category were soon determined to be related to this condition newer medications such as anti angiogenic drugs have been potentially implicated causing a very similar condition and consensus shifted to refer to the related conditions as mronj however this has not been definitively demonstrated there is no known prevention for bisphosphonate associated osteonecrosis of the jaw avoiding the use of bisphosphonates is not a viable preventive strategy on a general population basis because the medications are beneficial in the treatment and prevention of